Pages that link to "Q36728525"
Jump to navigation
Jump to search
The following pages link to The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation (Q36728525):
Displaying 28 items.
- Identification of a novel liver-specific expressed gene, TCP10L, encoding a human leucine zipper protein with transcription inhibition activity (Q24298751) (← links)
- The ornithine decarboxylase gene is a transcriptional target of c-Myc (Q24561758) (← links)
- Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery (Q26795703) (← links)
- Dynamic in vivo interactions among Myc network members (Q28212240) (← links)
- Mutation of the MXI1 gene in prostate cancer (Q28302634) (← links)
- Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages (Q30311252) (← links)
- Therapeutic Targeting of Myc. (Q34373258) (← links)
- Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation (Q34769296) (← links)
- Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes (Q35548487) (← links)
- Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma. (Q35590573) (← links)
- Functions of myc:max in the control of cell proliferation and tumorigenesis (Q35885872) (← links)
- Differential patterns of DNA binding by myc and max proteins (Q36083463) (← links)
- Permanently blocked stem cells derived from breast cancer cell lines. (Q36554652) (← links)
- Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc (Q36638977) (← links)
- Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells (Q36819218) (← links)
- A point mutation in the MyoD basic domain imparts c-Myc-like properties (Q37218369) (← links)
- Determination of the c-MYC DNA-binding site (Q37548298) (← links)
- Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias (Q37589603) (← links)
- c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II (Q37635815) (← links)
- Myc target in myeloid cells-1, a novel c-Myc target, recapitulates multiple c-Myc phenotypes (Q38290959) (← links)
- Low molecular weight inhibitors of Myc-Max interaction and function (Q40633710) (← links)
- Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family (Q40864825) (← links)
- Relationship between myc oncogene activation and MHC class I expression. (Q40867760) (← links)
- Protein kinase C isoenzymes: divergence in signal transduction? (Q40902836) (← links)
- Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells (Q41676045) (← links)
- Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc (Q41685649) (← links)
- Distinct Roles for MAX Protein Isoforms in Proliferation and Apoptosis (Q42798685) (← links)
- Mmip-2/Rnf-17 enhances c-Myc function and regulates some target genes in common with glucocorticoid hormones (Q43649376) (← links)